Comerica Bank’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Buy |
4,124
+1,497
| +57% | +$7.58K | ﹤0.01% | 3041 |
|
|
2025
Q1 | $13.9K | Sell |
2,627
-118
| -4% | -$624 | ﹤0.01% | 3108 |
|
|
2024
Q4 | $18.6K | Buy |
2,745
+268
| +11% | +$1.81K | ﹤0.01% | 3055 |
|
|
2024
Q3 | $16.3K | Sell |
2,477
-1,174
| -32% | -$7.74K | ﹤0.01% | 3080 |
|
|
2024
Q2 | $27.4K | Buy |
3,651
+65
| +2% | +$488 | ﹤0.01% | 2914 |
|
|
2024
Q1 | $35.8K | Buy |
3,586
+748
| +26% | +$7.46K | ﹤0.01% | 2857 |
|
|
2023
Q4 | $28K | Buy |
2,838
+2,572
| +967% | +$25.4K | ﹤0.01% | 2884 |
|
|
2023
Q3 | $2.04K | Buy |
+266
| New | +$2.04K | ﹤0.01% | 3567 |
|